Aflac Incorporated (NYSE:AFL) Shares Sold by Jaffetilchin Investment Partners LLC

Jaffetilchin Investment Partners LLC lessened its holdings in shares of Aflac Incorporated (NYSE:AFL) by 3.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,954 shares of the financial services provider’s stock after selling 225 shares during the period. Jaffetilchin Investment Partners LLC’s holdings in Aflac were worth $777,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Y.D. More Investments Ltd purchased a new stake in shares of Aflac during the 2nd quarter worth approximately $25,000. Covestor Ltd lifted its position in Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares during the last quarter. Kennebec Savings Bank purchased a new stake in Aflac in the third quarter valued at $45,000. Cedar Wealth Management LLC acquired a new position in Aflac in the first quarter valued at $50,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in shares of Aflac during the third quarter worth about $51,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of AFL stock opened at $110.44 on Tuesday. The company has a current ratio of 0.08, a quick ratio of 0.10 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a 12-month low of $75.07 and a 12-month high of $115.50. The company has a market cap of $61.35 billion, a price-to-earnings ratio of 16.63, a price-to-earnings-growth ratio of 2.10 and a beta of 0.96. The stock has a 50 day simple moving average of $110.33 and a 200-day simple moving average of $98.76.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The company had revenue of $2.95 billion during the quarter, compared to the consensus estimate of $4.30 billion. During the same quarter last year, the company earned $1.84 earnings per share. Aflac’s quarterly revenue was down 40.4% compared to the same quarter last year. On average, equities analysts forecast that Aflac Incorporated will post 7.17 EPS for the current year.

Aflac Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 annualized dividend and a yield of 1.81%. Aflac’s payout ratio is currently 30.12%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on AFL. UBS Group upped their target price on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research report on Wednesday, August 14th. TD Cowen assumed coverage on shares of Aflac in a research report on Wednesday, October 9th. They set a “hold” rating and a $102.00 target price on the stock. Bank of America lifted their target price on shares of Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Barclays began coverage on shares of Aflac in a research note on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price target for the company. Finally, Piper Sandler lifted their price objective on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $97.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.